The name Cryoport Inc. (CYRX) should be kept on your radar

As of close of business last night, Cryoport Inc.’s stock clocked out at $23.73, up 2.59% from its previous closing price of $23.13. In other words, the price has increased by $+0.60 from its previous closing price. On the day, 678823 shares were traded. CYRX stock price reached its highest trading level at $24.54 during the session, while it also had its lowest trading level at $23.01.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

To gain a deeper understanding of CYRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.40 and its Current Ratio is at 15.00. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.75.

Upgrades & Downgrades

On November 05, 2021, ROTH Capital Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $78 to $90.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 01 when BERMAN RICHARD J sold 7,250 shares for $19.63 per share. The transaction valued at 142,316 led to the insider holds 0 shares of the business.

BERMAN RICHARD J sold 2,708 shares of CYRX for $116,588 on Aug 16. The Director now owns 107,203 shares after completing the transaction at $43.05 per share. On Aug 11, another insider, Hariri Robert J, who serves as the Director of the company, sold 2,000 shares for $43.29 each. As a result, the insider received 86,581 and left with 7,911 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 4.95 while its Price-to-Book (P/B) ratio in mrq is 2.13.

Stock Price History:

Over the past 52 weeks, CYRX has reached a high of $45.36, while it has fallen to a 52-week low of $15.63. The 50-Day Moving Average of the stock is 18.82, while the 200-Day Moving Average is calculated to be 26.81.

Shares Statistics:

It appears that CYRX traded 555.28K shares on average per day over the past three months and 516.08k shares per day over the past ten days. A total of 48.52M shares are outstanding, with a floating share count of 48.08M. Insiders hold about 1.87% of the company’s shares, while institutions hold 96.00% stake in the company. Shares short for CYRX as of Oct 13, 2022 were 3.4M with a Short Ratio of 3.39M, compared to 2.83M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 7.01% and a Short% of Float of 7.20%.

Earnings Estimates

As of right now, 9 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.06 and a low estimate of -$0.18, while EPS last year was -$0.18. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.04 and low estimates of -$0.17.

Analysts are recommending an EPS of between -$0.64 and -$0.89 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.21, with 9 analysts recommending between $0.56 and -$0.6.

Revenue Estimates

In the current quarter, 9 analysts expect revenue to total $70.1M. It ranges from a high estimate of $71.72M to a low estimate of $67.44M. As of the current estimate, Cryoport Inc.’s year-ago sales were $56.69M, an estimated increase of 23.60% from the year-ago figure. For the next quarter, 9 analysts are estimating revenue of $74.22M, an increase of 31.50% over than the figure of $23.60% in the same quarter last year. There is a high estimate of $75.95M for the next quarter, whereas the lowest estimate is $69.73M.

A total of 9 analysts have provided revenue estimates for CYRX’s current fiscal year. The highest revenue estimate was $263.4M, while the lowest revenue estimate was $253.63M, resulting in an average revenue estimate of $260.71M. In the same quarter a year ago, actual revenue was $222.61M, up 17.10% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $321.78M in the next fiscal year. The high estimate is $368.33M and the low estimate is $303.7M. The average revenue growth estimate for next year is up 23.40% from the average revenue estimate for this year.